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Abstract
Introduction We conducted the present study to evaluate the
changes in serum total antioxidant capacity (TAC) in patients
with severe sepsis and to investigate the association between
serum TAC and clinical severity.
Method This was a prospective observational study involving a
sample of patients who met established criteria for severe
sepsis and were admitted to the emergency department of a
university teaching hospital. Serum TAC was determined using
the total radical-trapping antioxidant parameter method. The
levels of TAC, uric acid, albumin, and bilirubin in sera were
obtained in the emergency department and evaluated to
determine whether there were any correlations between the
major antioxidant biomarkers and clinical severity of sepsis. The
Acute Physiology and Chronic Health Evaluation (APACHE) II
score was used for clinical evaluation of the severity of sepsis.
Results A total of 73 patients with sepsis, with a mean (±
standard deviation) APACHE II score of 23.2 ± 8.2 and a
mortality rate of 26.0%, were included. Seventy-six healthy
individuals served as control individuals. Among the patients,
serum TAC levels correlated significantly with APACHE II
scores. Patients who died also had higher TAC than did those
who survived. Serum uric acid levels correlated significantly with
serum TAC and APACHE II scores in patients with severe
sepsis.
Conclusion Elevated serum TAC level may reflect clinical
severity of sepsis. In addition, serum uric acid levels appear to
contribute importantly to the higher TAC levels observed in
patients with severe sepsis.
Introduction
Severe sepsis is a challenging problem in the emergency
department or intensive care unit (ICU) [1], and can lead to
septic shock or multiple organ failure. The complex mecha-
nisms underlying severe sepsis remain unclear. In sepsis, the
overwhelming inflammatory response to the invading patho-
gen is the major pathophysiologic challenge, rather than the
pathogen itself. In a systemic inflammatory response, both
endothelial cells and neutrophils are activated to release oxy-
gen-derived free radicals [2]. It seems that these oxyradicals
play a role in causing or propagating the systemic inflamma-
tory response syndrome (SIRS) in life-threatening conditions,
and that the imbalance in redox state reflects both oxidative
stress and tissue damage [3,4].
Measurement of serum total antioxidant capacity (TAC) level
was reported to provide an integrated index, as opposed to
one based on simple summation of measurable antioxidants
[5]. It possibly could be used to assess the real change in anti-
oxidant status in patients with severe sepsis and might lead to
universally useful treatment [6]. Several preclinical and clinical
studies of sepsis focused on single-point inhibition (for exam-
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ple, anti-tumor necrosis factor antibodies) or augmentation of
specific key processes, and failed to demonstrate therapeutic
efficacy [7]. Most believe that higher levels of oxyradicals and
lower antioxidant levels in patients with SIRS or septic shock
lead to multiple organ failure [8-10]. However, serum TAC
increases in critically surgical patients with septic shock [11].
Moreover, endogenous peroxyl-radical scavenging ability in
the plasma of SIRS patients was found to be elevated in non-
survivors [12]. The actual change in TAC in severe sepsis
remains controversial.
Serum uric acid (UA), like other antioxidants such as albumin,
bilirubin, or vitamins A, C and E, is a powerful free-radical scav-
enger and increases in response to acute oxidative stress
[11,13]. UA formation may even provide a significant antioxi-
dant defense mechanism against nitration by peroxynitrite in
rat heart during hypoxia [14]. It is therefore postulated that
serum UA level is an important marker in oxidative stress.
Recently, serum UA was identified as a strong predictor of
mortality in patients with moderate-to-severe chronic heart fail-
ure [15]. This finding raises an interesting question about the
actual pathophysiologic role of serum UA in critically ill
patients.
We conducted the present study to investigate whether serum
TAC levels are elevated or suppressed in emergency depart-
ment patients with severe sepsis. We also wished to deter-
mine the correlation between serum TAC level and severity of
illness, and the relationship between serum TAC and UA levels
in emergency department patients with severe sepsis.
Materials and methods
The study was conducted between April 2001 and March
2003 at an academic tertiary care center, which receives
between 43,000 and 54,000 emergency department visits
each year. The study was approved by our hospital's Institu-
tional Research Review Board.
Patients selection
Patients aged 18 years old or older meeting criteria for severe
sepsis (including septic shock) were recruited into the study,
after consent had been obtained from the relatives of the
patients. The inclusion criteria used for severe sepsis were
those defined by the American College of Chest Physicians/
Society of Critical Care Medicine Consensus Conference
[16]. 'Severe sepsis' is defined as sepsis associated with
organ dysfunction, hypoperfusion abnormality, or sepsis-
induced hypotension. 'Septic shock' is a subset of severe sep-
sis and is defined as sepsis-induced hypotension that persists
despite adequate fluid resuscitation combined with hypoper-
fusion/organ dysfunction [16]. Patients with noninfectious dis-
eases such as acute coronary syndrome, acute stroke, acute
pancreatitis, drug intoxication, and severe renal dysfunction
(serum creatinine >3.0 mg/dl) were excluded. All patients
were first evaluated in the emergency department and were
then observed throughout the duration of the admission to
identify possible sources of infection. We also included 76
healthy control individuals, selected from those undergoing an
annual health examination, who were matched to the patients
with respect to age and sex.
Laboratory determinations
Peripheral venous blood samples available in the emergency
department were put into sterile collection tubes without anti-
coagulant and centrifuged at 3,500 rpm for 15 minutes. The
supernatants were aliquoted into Eppendorf tubes and stored
at -70°C until analysis.
Measurements of serum total antioxidant capacity and 
other serum biomarkers
Serum TAC, UA, albumin, and bilirubin were measured as indi-
cators of antioxidative status. Serum levels of TAC and UA
were determined within six hours after a patient had arrived in
the emergency department. Serum TAC was assessed using
the total radical-trapping antioxidant parameter (TRAP)
method [17] and on a luminometer (AutoLumat LB 953; EG &
G Berthold, Bad Wildbad, Germany) to determine the TAC
level, as previously described [18]. Briefly, a chemilumines-
cent reaction was generated in a collection tube by carefully
mixing 800 µl distilled water, 100 µl signal reagent (luminol
and p-iodophenol in buffer solution), and 50 µl 1:200 diluted
horseradish peroxidase solution (Sigma, St. Louis, MO, USA).
Then, 10 µl of the sample was added to inhibit the lumines-
cence. The duration of quenching was measured and com-
pared with that of water-soluble ascorbic acid. The precision
of the assay (coefficient of variation) was 2.3% for within-day
variation and 5.1% for day-to-day variation. Serum concentra-
tions of UA, albumin, and bilirubin were determined using com-
mercial kits and an automated biochemical analyzer (Hitachi
747; Roche Diagnostics, Mannheim, Germany).
Evaluation of clinical severity and primary outcome
The Acute Physiology and Chronic Health Evaluation
(APACHE) II score [19] is used to evaluate the severity of dis-
ease. APACHE II score was the first system to use a quantita-
tive evaluation of disease severity in the ICU [20], and the
score was calculated within 24 hours of emergency depart-
ment admission. The primary outcome was whether the serum
TAC correlated with APACHE II score in patents with severe
sepsis. The secondary outcome was 28-day in-hospital mortal-
ity. In order to evaluate the relative contribution of serum TAC
to patient outcome, patients were divided into 'survivors' and
'nonsurvivors'. Survivors were those patients who were still
alive 28 days after admission, including an ICU stay; nonsurvi-
vors were patients who died within 28 days of emergency
department admission.
Statistical analysis
All values were expressed as the mean ± standard deviation.
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II score, length of stay, and age were recorded and analyzed
using SPSS for Windows 11.5 (SPSS, Chicago, IL, USA).
Prevalence and associated 95% confidence intervals were
calculated using conventional methodology [21]. The compar-
isons among serum TAC levels and among groups with differ-
ent APACHE II scores were made using one-way analysis of
variance and post-hoc comparisons ('least significant differ-
ence'). Spearman rank nonparametric correlation was used to
estimate the correlation between TAC levels and each of UA,
albumin, bilirubin, and APACHE II score. Comparisons
between survivors and nonsurvivors were conducted using the
Mann-Whitney U exact test. P < 0.05 was considered statisti-
cally significant. Multiple linear regressions were used to
assess the associations between serum TAC levels and
APACHE II scores after controlling for covariates such as age
and serum creatinine levels.
Results
The study enrolled 149 participants aged over 18 years: 73
patients who met the criteria for severe sepsis (including sep-
tic shock), as defined by the American College of Chest Phy-
sicians/Society of Critical Care Medicine Consensus
Conference; and 76 healthy control individuals. These patients
(41 men and 32 women; mean age 65.9 ± 16.4 years) pre-
sented with a mean APACHE II score of 23.2 ± 8.2; the mor-
tality rate was 26.0% (19 out of 73; Table 1). Of the patients,
39 (53.4%) had pneumonia, nine (12.3%) had soft tissue
infections (including necrotizing fasciitis and Fournier gan-
grene, among others), seven (9.6%) had urinary tract infec-
tions, six (8.2%) had biliary tract infections, three (4.1%) had
central nervous system infections (including brain abscess,
meningitis, among others), and nine (12.3%) had unknown
foci of infection. Nonsurvivors had higher APACHE II scores
and a higher ratio of septic shock in the emergency depart-
ment than did survivors. The leading infectious micro-organism
were Gram-negative bacteria (35.6%) and the positive culture
rate was 75.3% (55 out of 73). Detailed demographic data,
clinical diagnoses, and microbiological data for patients and
healthy control individuals are summarized in Table 1.
Table 1
Characteristics of patients with severe sepsis and of healthy control individuals
Patients with severe sepsis
Characteristic Survivors (n = 54) Nonsurvivors (n = 19) Healthy controls (n = 76)
Age (years) 65.1 ± 17.0 68.4 ± 14.6 65 ± 7.9
Gender (male/female) 29/25 12/7 43/33
APACHE II score 21.0 ± 7.3 29.4 ± 7.8* -
Septic shock (emergency department visit) 27 (50.0%) 15 (78.9%)* -
Length of stay in ICU (days) 29.2 ± 20.2 9.7 ± 11.0*
Diagnoses of severe sepsis (n [%])
Pneumonia 29 (53.7) 10 (52.6)
Soft tissue infections 8 (14.8) 1 (5.3)
Urinary tract infections 6 (11.1) 1 (5.3)
Biliary tract infections 5 (9.3) 1 (5.3)
Central nervous system infections 1 (1.8) 2 (10.5)
Unknown foci 5 (9.3) 4 (21.0)
Microbiological data (n)
Gram-negative bacteria 21 5
Gram-positive bacteria 12 3
Polybacterial 8 2
Fungi 3 0
Positive culturesa 45 10
Positive bacteremiasb 20 5
Data are shown as mean ± standard deviation, unless otherwise stated. *P < 0.05, versus survivors. aRates of positive culture; samples include 
sputum, urine, and other tissues. bRates of positive blood culture.Critical Care    Vol 10 No 1    Chuang et al.
Page 4 of 7
(page number not for citation purposes)
Correlation between serum total antioxidant capacity 
level and clinical severity
Serum TAC levels in patients with severe sepsis correlated
positively with APACHE II scores (r = 0.426, 95% confidence
interval [CI] 0.2–0.6; P <0.001; Figure 1). After controlling for
age and serum creatinine level, TAC still exhibited a positive
correlation with APACHE II score (P = 0.027).
Comparison of serum total antioxidant capacity levels in 
healthy control individuals and patients
Serum TAC levels were significantly higher in patients with
severe sepsis than in healthy control individuals (637.0 ±
290.9 µmol/L versus 355.2 ± 102.7 µmol/L, 95% CI 211.7–
351.9; P <0.001). Furthermore, serum TAC levels were higher
in nonsurvivors than in survivors (812.0 ± 322.4 µmol/L versus
575.4 ± 254.6 µmol/L, 95% CI 91.2–382.0; P = 0.002; Fig-
ure 2).
Correlation between serum total antioxidant capacity 
and uric acid, bilirubin, and albumin levels in patients
Serum TAC levels in patients with severe sepsis were signifi-
cantly and positively correlated with serum UA levels (r  =
0.726, 95% CI 0.595–0.819; P <0.001; Figure 3). No corre-
lation was found between serum TAC and albumin level.
Serum TAC levels exhibited a weak but significant correlation
with bilirubin levels (r = 0.311, 95% CI 0.1–0.5; P = 0.02).
Correlation between serum uric acid and clinical severity 
in patients
Serum UA exhibited a weak but significant correlation with
APACHE II score (r  = 0.306, 95% CI 0.082–0.501; P  =
0.009; Figure 4). However, there was no significant correlation
of serum albumin or bilirubin level with APACHE II score.
Discussion
In this study we showed that serum TAC levels reflected clini-
cal severity of sepsis. Serum TAC levels became elevated as
APACHE II scores rose. In addition, serum TAC levels were
higher in nonsurvivors than in survivors. Why serum TAC
increased in patients with severe sepsis is unknown. It is
hypothesized that anti-inflammatory processes are activated to
counterbalance excessive levels of proinflammatory cytokines
[22] or oxidative stress [23]. It is also possible that altered anti-
oxidant defense (i.e. a significant change in serum TAC level)
eventually leads to immune dysfunction and a poor outcome
[11,12,24].
Higher sustained serum TAC levels, as noted in the nonsurvi-
vors, might be a host response to severely propagating oxida-
tive stress or a compensating mechanism for depleted
antioxidative components [13]. It is also possible that the
increase in serum TAC simply worsened severe sepsis, which
suggests that antioxidant therapy should not routinely be used
in the treatment of severe sepsis until its mechanism of action
is understood.
TAC levels in patients with severe sepsis remain controversial.
Although Ghiselli and coworkers [5] suggested that plasma
rather than serum should be used to measure TAC levels, in
the study by Whitehead colleagues [17] and in ours [18]
serum was used. In one of our other experiments there
appeared to be no significant difference between the levels
detected in plasma and serum (data not shown). Pascual and
coworkers [11] reported that plasma TAC levels were lower in
patients with sepsis but higher in patients with septic shock
Figure 1
Correlation between serum TAC and APACHE II score in patients with  severe sepsis Correlation between serum TAC and APACHE II score in patients with 
severe sepsis. A total of 73 patients were included in the study. 
APACHE, Acute Physiology and Chronic Health Evaluation; TAC, total 
antioxidant capacity.
Figure 2
Serum TAC in control and patients (stratified by outcome) Serum TAC in control and patients (stratified by outcome). The trial 
included a total of 76 healthy control individuals; of the 73 patients, 54 
survived ('survivors') and 19 died ('nonsurvivors'). The horizontal bars 
represent the mean level for each group. TAC, total antioxidant capac-
ity.Available online http://ccforum.com/content/10/1/R36
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than in control individuals. MacKinnon and colleagues [13], in
a study conducted in 50 critically ill patients, reported that total
antioxidant status and UA levels were higher in nonsurvivors
than in survivors, and speculated that the higher total antioxi-
dant status level might have reflected the higher UA levels
caused by renal dysfunction. In accordance with our findings,
Tsai and coworkers [12] reported that plasma TAC levels were
significantly higher in nonsurvivors than in survivors. However,
most other studies [2,8,25] found that the plasma antioxidant
potentials of nonsurvivors were significantly lower than those
of survivors among patients with severe sepsis.
The discrepancy in the findings from these studies may mainly
be due to differences in measurement methods. Instead of
using a spectrophotometric method [2], we and two other
groups [11,12] used the TRAP method to measure the total
antioxidant potential. The spectrophotometric method, pro-
posed by Miller and coworkers [26], measures the reaction of
plasma antioxidants and a mixture of different radical species
including 2,2'-azinobis(3-ethylbenzothiazoline 6-sulfonic acid;
ABTS) radical cation, ferryl myoglobin, hydrogen peroxide, and
other radicals. In the spectrophotometric methods, albumin
and UA account for 43% and 33%, respectively, of TAC. The
marked decrease in serum albumin in patients with severe
sepsis may lead to lower levels of TAC detected using the
spectrophotometric method. On the other hand, the TRAP
method measures the reaction of total antioxidants and peroxyl
radicals generated by 2,2'-azobis(2-amidinopropane hydro-
chloride; ABAP) [27]. The contribution of albumin to the TRAP
reaction is very low (<10%), whereas that of UA is higher (47–
57%, but even up to 76.4%). Therefore, change in serum UA
may influence serum TAC levels determined using the TRAP
method.
Our findings also indicate a significant increase in serum UA
and a positive correlation between serum UA and TAC in
patients with severe sepsis and septic shock. In addition,
serum UA levels correlated significantly with APACHE II
scores. Similarly, a study of neonatal sepsis [28] found that
serum UA concentrations were increased by 51% in babies
with septic shock as compared with control babies. Jabs and
coworkers [29] also found that plasma UA levels increased in
relation to higher APACHE II scores in critically ill patients. All
of these findings suggest that serum UA is an important con-
tributor to serum TAC, which in turn may reflect the clinical
severity of severe sepsis. The mechanism of increased UA in
patients with severe sepsis and septic shock is unknown. Both
increased production and decreased excretion of UA may
result in elevated serum level. Severe sepsis and septic shock
may induce ischemia or hypoxia in multiple organs, which fur-
ther increases the change in xanthine/hypoxanthine to UA
through activation of xanthine oxidase in microvascular
endothelium [30,31]. On the other hand, renal dysfunction
induced by septic shock may reduce the secretion of UA from
the kidneys, which may increase serum UA and further elevate
serum TAC [5,13]. In the present study, we excluded patients
with previous renal dysfunction and patients undergoing
hemodialysis. Therefore, our finding of increased serum UA or
TAC in patients with severe sepsis or septic shock could not
have been a consequence of renal failure. Whether hyperuri-
cemia is a risk factor for severe sepsis is unknown. Our find-
ings simply demonstrate that serum UA levels were correlated
with APACHE II scores, and indicate that hyperuricemia might
be associated with poorer clinical outcomes in sepsis. In this
Figure 3
Correlation between serum TAC and UA in patients with severe sepsis Correlation between serum TAC and UA in patients with severe sepsis. 
A total of 73 patients were included in the study. TAC, total antioxidant 
capacity; UA, uric acid.
Figure 4
Correlation between serum UA and APACHE II score in patients with  severe sepsis Correlation between serum UA and APACHE II score in patients with 
severe sepsis. A total of 73 patients were included in the study. 
APACHE, Acute Physiology and Chronic Health Evaluation; UA, uric 
acid.Critical Care    Vol 10 No 1    Chuang et al.
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study elevation of serum UA could not represent TAC com-
pletely. More studies are needed to investigate the mechanism
underlying the relation between serum UA and sepsis.
Conclusion
Serum TAC levels were elevated in severe sepsis, especially
in nonsurvivors, and were positively correlated with clinical
severity. Serum UA, which contributes largely to TAC level,
plays an important role in elevating serum TAC in patients with
severe sepsis. Further studies are needed to confirm our
observations and elucidate the underlying mechanisms.
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